Get started
Author

Hailong Tang

Observed names: H Tang, H. Tang, Hai-Long Tang, Tang H, Tang, Hailong
Observed institutions: Chinese Academy of Sciences, Nantong University, Zhengzhou University, Henan Cancer Hospital, Xijing Hospital, Chinese People's Liberation Army, State Key Laboratory of Cancer Biology, Nantong University Xinglin College, Air Force Medical University
ORCID: 0000-0003-2876-0696
Observed ORCID: 0000-0003-2876-0696
OpenAlex ID: A5084046149
A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide
1998 · J Sun, D N Fass, et al. · Clinical & Experimental Immunology · 352
PDF
Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma
2006 · H. Xie, J. Song, et al. · Digestive and Liver Disease · 57
PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer
2022 · Ping Gao, Jing-Lan Hao, et al. · Oncogene · 25
PDF
Chidamide epigenetically represses autophagy and exerts cooperative antimyeloma activity with bortezomib
2020 · Li Xu, Juan Feng, et al. · Cell Death and Disease · 24
PDF
Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution
2017 · Chun Cao, Juan Feng, et al. · Annals of Diagnostic Pathology · 24
Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review.
2015 · Guang-Xun Gao, Hai-Long Tang, et al. · PubMed · 20
The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects
2022 · Hong-Yuan Shen, Hai-Long Tang, et al. · Journal of Oncology · 19
PDF
Pharmacological inhibition of EZH2 combined with DNA‑damaging agents interferes with the DNA damage response in MM cells
2019 · Li Xu, Hailong Tang, et al. · Molecular Medicine Reports · 16
PDF
BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis
2020 · Guang Li, Yan-Hua Zheng, et al. · Therapeutic Advances in Hematology · 15
PDF
Momelotinib for the treatment of myelofibrosis
2019 · Li Xu, Juan Feng, et al. · Expert Opinion on Pharmacotherapy · 14
Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials
2018 · Yanhua Zheng, Hongyuan Shen, et al. · Journal of Immunology Research · 13
PDF
Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens
2022 · Xiao Liu, Shuangshuang Jia, et al. · Frontiers in Oncology · 12
PDF
Low dose dinaciclib enhances doxorubicin‑induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathways
2018 · Hailong Tang, Li Xu, et al. · Oncology Letters · 12
PDF
Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia
2022 · Lei Bi, Shuangshuang Jia, et al. · BMC Medical Genomics · 11
PDF
Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis
2020 · Jianhong Wang, Xiaohui Duan, et al. · Cell Transplantation · 11
PDF
A new chemotherapy‐free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study
2024 · Hailong Tang, Weijing Jia, et al. · American Journal of Hematology · 10
PDF
CDK5 inhibition in�vitro and in vivo induces cell death in�myeloma and overcomes the obstacle of bortezomib resistance
2020 · Hailong Tang, Li Xu, et al. · International Journal of Molecular Medicine · 10
PDF
Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis
2019 · Yan-Hua Zheng, Li Xu, et al. · OncoTargets and Therapy · 10
PDF
[Inducing effect of chidamide on apoptosis of multiple myeloma cells and its relerance to DNA damage response].
2015 · Li Xu, Hai-Long Tang, et al. · PubMed · 9
Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
2022 · Shuangshuang Jia, Lei Bi, et al. · Frontiers in Oncology · 8
DNA damage response-initiated cytokine secretion in bone marrow stromal cells promotes chemoresistance of myeloma cells
2017 · Hailong Tang, Mimi Shu, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Allogeneic bone marrow transplantation for the treatment of leukemia.
1990 · D P Lu, N L Guo, et al. · PubMed · 5
Causal associations between the gut microbiota and multiple myeloma: a two-sample Mendelian randomization study
2024 · Chun-Yan Zhang, Dong Zhang, et al. · Frontiers in Nutrition · 3
[Influence of CD117 Expression on Response of Multiple Myeloma Patients to Chemotherapy].
2015 · Hai-Long Tang, Mi-Mi Shu, et al. · PubMed · 3
Treatment Options for Older Unfit Patients with Acute Myeloid Leukemia
2021 · Hailong Tang, Shuangshuang Jia, et al. · Future Oncology · 2
Works count: 36
Citation count: 697
H-index: 12
I10-index: 18
Year
Topic
Type